A lower appeals court ruling allowing human genes to be patented has been overturned by the U.S. Supreme Court, which sends the case back down for a continuation of the battle between those who believe that genes carrying the secrets of life should not be exploited for commercial gain and companies who argue that a patent must be the reward for years of expensive research that moves science forward.
The ruling again overturns patents belonging to Myriad Genetics Inc. of Salt Lake City on two genes linked to increased risk of breast and ovarian cancer. Myriad's BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA. Now they must go back for a rehearing and the impact could be substantial.
The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.
The case is Association for Molecular Pathology v. Myriad Genetics, 11-725.
Supreme Court throws out human gene patents, Associated Press, Monday, March 26, 2012
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- "I was going to write exactly the same comment as KJ (though probably not as well). Hang around..."
- "Tommaso, This is an interesting question - thanks for sharing. I disagree with your answer to part..."
- "Hmm...a few thoughts: 1. Because, if the take-home message from this award is that people should..."
- "Hello Maurice,indeed this prize must collectively be felt as a prize to superK, I guess...."
- "There's room on this planet for quackery too, that doesn't mean it's good. It is a professional..."
- Why Is Mother Jones So Afraid Of Science? And Journalism?
- Weight-Loss Surgery Improves Health of Some Diabetics
- Ben Carson Bungles Again, Treating Cancer with Supplements
- No Vax, No School: US Supreme Court Backs NY State
- Remaking the Peanut to Make Schools Safer
- Ancient Chinese Medicine Not Magical, Nobel Prize or Not